Image Place holder

Sameh Gaballa, MD


Specialty: Medical Oncology
Program: Malignant Hematology

Call 1-888-MOFFITT
(1-888-663-3488)

Call 1-888-MOFFITT
(1-888-663-3488)

Overview

Cancer Focus: Hodgkin Lymphoma , Leukemia , Non-Hodgkin Lymphoma

Dr. Sameh Gaballa is an Assistant Member in the Moffitt Cancer Center Department of Malignant Hematology. Dr. Gaballa earned his MD from Ain Shams University in Cairo, Egypt. He completed an Internal Medicine Residency and a Hematology and Medical Oncology Fellowship at Thomas Jefferson University Hospital in Philadelphia, Pennsylvania. He then completed a Stem Cell Transplantation and Cellular Therapy Fellowship at the University of Texas MD Anderson Cancer Center. Dr. Gaballa previously practiced in the Thomas Jefferson University, Division of Hematologic Malignancies and Blood and Marrow Transplantation. Dr. Gaballa’s clinical interests are treating patients with lymphoid malignancies, including Non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and chronic lymphocytic leukemia. He is also interested in incorporating novel approaches such as chimeric antigen receptor T-cell therapy. His research focuses on developing novel targeted agents for treating patients with indolent (slow growing) lymphomas such as follicular lymphoma, marginal zone lymphoma and lymphoplasmacytic lymphomas. 

Education & Training

Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.

Publications

  • Grosso D, Leiby B, Carabasi M, Filicko-O'Hara J, Gaballa S, O'Hara W, Wagner JL, Flomenberg N. The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplantation. Front Oncol. 2019 Sep.9:888. Pubmedid: 31608225. Pmcid: PMC6758597.
  • Rhoades R, Gaballa S. The Role of B Cell Targeting in Chronic Graft-Versus-Host Disease. Biomedicines. 2017 Oct.5(4). Pubmedid: 29039818. Pmcid: PMC5744085.